Corcept Therapeutics | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Alaunos Therapeutics USD 3.55M 1.13M 2024-09
ANI Pharmaceuticals USD 527.68M 6.39M 2024-12
Ardelyx USD 356.45M 72.35M 2024-12
Aurora Cannabis CAD 494.21M 76.54M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
J&J USD 55.89B 2.64B 2024-12
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Merck USD 38.78B 1.58B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 745.13M 55.16M 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
TG Therapeutics USD 566.36M 7.71M 2024-12



Corcept Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.